News Headlines Article

Study Sees Heart Risk in Meridia Diet Pill
New York Times

A clinical trial of Meridia, a controversial diet pill, in nearly 10,000 overweight or obese older patients over many years found that the drug increased the risks of heart attacks and strokes while doing little to slim their waists. The study was paid for by Abbott Laboratories, Meridia’s maker, and published in The New England Journal of Medicine. And the authors of the study, three of whom are Abbott employees, concluded that the trial results did little more than show that patients with heart problems should not be prescribed Meridia — a restriction already included in Meridia’s label.